Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

Presentation TCT 2019

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Presenter: David Kandzari

September 27, 2019

Presentation

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

April 18, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation TCT 2016

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Jaya Chandrasekhar

October 31, 2016

Presentation

Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly

Presenter: T.W. Yeh

December 12, 2013

Presentation TCT 2012

Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients.

Presenter: Hirotoshi Watanabe, Kyohei Yamaji, Yoshimitsu Soga, Shinichi Shirai, Kenji Ando, Koyu Sakai, Katsuhiro Kondo, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi

January 03, 2012

Presentation TCT 2012

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Presenter: Giulio G. Stefanini, Bindu Kalesan, Lorenz Raber, Thomas Pilgrim, Yoshinobu Onuma, Sigmund Silber, Patrick W. Serruys, Bernhard Meier, Peter Juni, Stephan Windecker

January 03, 2012

Advertisement

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials

Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly

Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients.

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content